and S.F
Gut Microbes 12:1801301 Santos LP, Gigante DP, Delpino FM, Maciel AP, Bielemann RM (2022) Sugar sweetened beverages intake and risk of obesity and cardiometabolic diseases in longitudinal studies: a systematic review and meta-analysis with 1.5 million individuals
Participants in Phase III trials are carefully selected and monitored, receive structured dose escalation, and have regular clinical follow-up
Several peripheral and central mechanisms are believed to be involved, including altered gut hormone secretion, decrease in energy expenditure following weight loss, and psychological processes associated with the food reward system
Although the modes of action for both GH43_8 and AA5 are currently unknown their enrichment in the AGAu group may provide a function-targeted biomarker for Candida infections 135,136
Tirzepatide typically shows weight loss effects after sustained treatment at a therapeutic dose